版本:
中国

BRIEF-GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older

Nov 21 Glaxosmithkline Plc :

* GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐